CN Patent

CN120289432B — 一种具有极光激酶b和表皮生长因子受体双重抑制作用的喹啉类化合物及用途

Assigned to Shanghai University of Medicine and Health Sciences · Expires 2025-09-05 · 1y expired

What this patent protects

本发明公开了一种喹啉类化合物，其结构通式选自如下任意一种： 、 等。本发明还提供了上述的化合物在制备作为具有极光激酶B和表皮生长因子受体双重抑制作用的药物中的用途。采用上述化合物制备的药物具有抗非小细胞肺癌的效果。

USPTO Abstract

本发明公开了一种喹啉类化合物，其结构通式选自如下任意一种： 、 等。本发明还提供了上述的化合物在制备作为具有极光激酶B和表皮生长因子受体双重抑制作用的药物中的用途。采用上述化合物制备的药物具有抗非小细胞肺癌的效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN120289432B
Jurisdiction
CN
Classification
—
Expires
2025-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai University of Medicine and Health Sciences
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.